Join as Johnson & Johnson’s Penny Heaton, MD, Global Head of the Johnson & Johnson Office of the Chief Medical Officer, and Nauman Shah, Global Head of Innovative Medicine Business Development, discuss the company’s end-to-end innovation model of R&D and external partnering, highlighting the key role of drug discovery through partnerships to drive impact and accelerate a new standard of care.

Dr. Heaton will underscore J&J’s key strategic areas of focus and opportunity to bring life-saving treatments for patients. Nauman will share J&J’s business development strategy prioritizing transformational acquisitions, licensing, and partnership opportunities that advance J&J’s mission to save and improve lives.

This session will provide valuable insights into the current innovation landscape, spotlight how to match science with scale to drive impact, illuminate how to build effective partnerships with large pharmaceutical companies, and more.